Eikon Therapeutics Inc banner
E

Eikon Therapeutics Inc
NASDAQ:EIKN

Watchlist Manager
Eikon Therapeutics Inc
NASDAQ:EIKN
Watchlist
Price: 8.78 USD -6.99% Market Closed
Market Cap: $475m

Eikon Therapeutics Inc
Investor Relations

Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Roger M. Perlmutter M.D., Ph.D.
Chairman, President & CEO
No Bio Available
Mr. Michael A. Klobuchar
Chief Operating Officer
No Bio Available
Dr. Roy D. Baynes FACP, M.D., Ph.D.
Executive VP & Chief Medical Officer
No Bio Available
Dr. Eric Betzig Ph.D.
Co-Founder & Member of Scientific Advisory Board
No Bio Available
Dr. Alfred Lloyd Bowie Jr., Ph.D.
Treasurer & CFO
No Bio Available
Mr. Russ Berman
Chief Technology Officer
No Bio Available
Mr. Benjamin Bruno Thorner
Secretary, General Counsel & Chief Business Officer
No Bio Available
Ms. Barbara Howes M.B.A.
Chief People Officer
No Bio Available

Contacts

Address
CALIFORNIA
Hayward
230 Harriet Tubman Way
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett